ArticleFrontiers in immunology2023

Minimal residual disease guided radical chemoradiotherapy combined with immunotherapy after neoadjuvant immunochemotherapy followed by adjuvant immunotherapy for esophageal squamous cell cancer (ECMRD-001): a study protocol for a prospective cohort study.

Hesong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.